The Role of CT Chest Scan in the Pre-anesthetic Assessment of Suspected or Confirmed COVID -19 Patients

Overview

The role of CT scan of the chest in Pre-anesthetic assessment of the severity of COVID-19 and the correlations between CT measurements of the aortic and pulmonary arteries diameters and severity of pneumonia.

Full Title of Study: “The Use of Preoperative CT Chest Scan in the Pre-anesthetic Assessment of COVID-19”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Retrospective
  • Study Primary Completion Date: July 30, 2020

Detailed Description

Patients who were scheduled for emergency surgery during COVID-19 pandemic should have be screened for COVID pre-operatively given the prevalence f asymptomatic or mildly symptomatic cases that could be carriers to infection and possibly cause cross infection to the operating room staff especially the anesthetists who deal with the upper airway during intubation with high possibility of getting infected with SARS-COV 2 virus. Waiting respiratory tract PCR (RT-PCR) test for COVID can delay the surgery which may increase patients morbidity and mortality. RT-PCR test has limited sensitivity and specificity. Patients who are confirmed to have COVID-19 infection (have positive RT-PCR) or patients who have possible COVID-19 infection (have symptoms but were not tested with RT-PCR) will undergo non-enhanced CT scanning of the chest (without giving IV contrast). Chest CT scan will be interpreted by 2 Consultants radiologists with an experience of at least 10 years in their field. The radiologists are going to be requested to comment on the lung parenchyma, describing the findings , assess the pulmonary artery, aorta diameters and the aorta:pulmonary diameters ratio will be then calculated. The degree of pneumonia severity index will then be described as well. The radiologists will be blinded to the aim of the study. All data will be collected and then correlation between the data sets will be statistically tested.

Interventions

  • Radiation: Non-enhanced CT scan of the chest
    • Non-enhanced CT scan of the chest with multi-slice CT scan machine.

Clinical Trial Outcome Measures

Primary Measures

  • pneumonia severity.
    • Time Frame: 90 days
    • The pneumonia severity will be assessed by the radiologist.
  • Aorta diameter
    • Time Frame: 90 days
    • Aorta cross sectional diameter will be calculated by using cursor method on CT scan
  • Pulmonary artery diameter
    • Time Frame: 90 days
    • Pulmonary artery sectional diameter will be calculated by using cursor method on CT scan
  • Pulmonary artery diameter TO Aorta diameter ratio
    • Time Frame: 90 days
    • Pulmonary artery diameter TO Aorta diameter ratio will be calculated

Secondary Measures

  • Description of the lesions found in the CT scan
    • Time Frame: 90 days
    • The parenchymal lesions will be described by the radiologist

Participating in This Clinical Trial

Inclusion Criteria

  • All patients scheduled for emergency surgery with symptoms suggestive of COVID-19 infection. Exclusion Criteria:

  • Pregnancy. – Haemodynamic instability (Mean arterial blood pressure above 65 mmHg or the need for of inotropic drugs to maintain mean arterial blood pressure above 65 mmHg). – Active bleeding. – Any indication by the surgeon or the anesthesiologist to proceed for immediate surgery for the patient safety. – Patients refusal to do CT scanning.

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Investigator Details

  • Lead Sponsor
    • Tanta University
  • Provider of Information About this Clinical Study
    • Principal Investigator: MOHAMMED FAWZI ALI ABOSAMAK, ICU consultant – Tanta University

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.